BTM Nanodesign develops protein-based nanomaterials for biotechnological applications. Our material portfolio includes nanomaterials that have a superior antibody binding capacity, compared with alternative products on the market. In addition, our materials are produced sustainably using only microorganisms.
The core of protein-based nanomaterials are nanofibrils that are highly ordered and typically contains so-called β-sheets, which make them strong. Since the nanofibrils have a very high surface area-to-volume ratio, they are eminently suitable for biotechnological applications, as a large number of enzymes or other interesting proteins can be immobilized in a comparatively small volume.
Our protein-based nanomaterials, the nanofibrils, can reduce the dependency on fossil resources. Compared to alternatives in the traditional chemistry industry, the nanofibrils do not require large amounts of chemicals – such as solvents or other reactive compounds – in their production, which carries large sustainability benefits. The fibrils are produced in microorganisms, and the special qualities in the fibrils are achieved by modification of the DNA sequence in these microorganisms.
Read the latest news about BTM Nanodesign and stay connected with the progress
SLU Holding invests in BTM Nanodesign
As of the 18th of February SLU Holding becomes a shareholder in BTM Nanodesign by investing SEK 394 000 in the company.
Profile on co-founder Benjamin Schmuck
SLU interviews BTM Nanodesign co-founder Benjamin Schmuck on the early research at the base of the company.
BTM Nanodesign is founded
BTM is founded by researchers at the Swedish University of Agricultural Sciences (SLU)
Get in touch